To assess the pharmacokinetics, safety and tolerability of Abediterol administered once daily for 9 Days, in patients with asthma on Inhaled corticosteroids

Trial Identifier:	D6540C00006
Sponsor:	AstraZeneca
NCTID::	NCT03273127
Start Date:	September 2017
Primary Completion Date:	November 2017
Condition:	Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Translation
	German Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Germany	Berlin, Germany, 14050

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.